Starting a business is a dream for many people but the journey is not always easy European entrepreneurs often face challenges such as limited resources fierce competition and a lack of visibility in ...

Quadratech Diagnostics, a provider of high quality medical diagnostics and research products, announced a global launch of Factor-X Activator RVV-X (50U) as the latest addition to the Q-TOX range of ...

There are currently no FDA-approved treatments for FXS, a disease that affects approximately 1 in 4-5000 men and 1 in 6-8000 women globally.

Frontier Medicines Corp. has announced the selection of FMC-220, a first-in-class covalent small-molecule activator of p53 Y220C designed to address potency and tolerability challenges of noncovalent ...

In today competitive business environment scaling efficiently is essential for European entrepreneurs looking to thrive in both local and international markets Brand Activator founded by Samuel Zlatar ...

FMC-220 is a first-in-class covalent activator of p53Y220Cdesigned to address potency and tolerability challenges of non-covalent approachesIn ...